Dr. Marlene Martin, MD

Dr. Martin practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Martin's NPI, 1831465152, was assigned on March 30, 2012. Dr. Martin graduated from Stanford University School Of Medicine in 2012. Dr. Martin's California license number on file is A128191.

Dr. Martin's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Martin's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dr. Martin is also affiliated with Santa Clara Valley Medical Center. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Martin to 2 more medical groups, each named with a free account. Dr. Martin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Martin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Martin is board certified in internal medicine by the American Board of Internal Medicine. Dr. Martin has a license on file in California.

Dmand AI lists drug use disorders, electrolyte disorders, loss of balance, lung disease: COPD, asthma or bronchitis and sepsis among the conditions Dr. Martin treats.

CMS data shows 122 Medicare services from Dr. Martin across 4 procedure codes in 2024, for 42 Medicare patients. Medicare paid $11,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Martin in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 50% have alcohol and drug use disorders. Their average risk score is 3.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Martin's median patient age at 63, with 25% women.

In 2024, Dr. Martin wrote 48 Medicare Part D claims for 18 patients. 79% of them were for generic drugs. They cover 8 drugs, with $10,900 in total drug cost. In 2016, CMS named 140 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Martin for performance year 2024, reported as part of a group. Dr. Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 44 papers to Dr. Martin, published from 2008 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Opioid-Related Disorders, Substance-Related Disorders and Behavior, Addictive. Dr. Martin has published most often in J Addict Med. Dr. Martin's most frequent co-authors are Honora L. Englander, MD, Oanh Kieu Nguyen, MD and Susan Lynn Calcaterra, MD.

CMS Open Payments shows 1 general payment to Dr. Martin from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $74.

Dr. Martin graduated from Stanford University School Of Medicine in 2012.

Dr. Martin is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.